Perceptive Advisors Llc's Net Worth

Perceptive Advisors Llc's net worth is estimated to be at least $494,119,330.90 as of 01/31/2023. CoreStreet's estimation of Perceptive Advisors Llc's net worth is based on their sale of stock and current holding of stock.

Perceptive Advisors Llc is Director at Astria Therapeutics Inc. They have executed at least 98 trades of stock as per SEC Form 4 filings. Their most recent trade was for 908,265 units of ATXS stock on 12/19/2022. Their biggest sale was on 12/01/2021 when they sold 2,707,463 units of VBI Vaccines Inc stock for $8,961,702.53. They typically trade 9 times per year.

Total value of insider buys:
  • $440,866,831.27
Total value of insider sells:
  • $53,252,499.63
Most recent insider trade:
  • Dec. 19, 2022

Perceptive Advisors Llc's Insider Trading History

Astria Therapeutics IncTitleAmountPriceTypeTotal Value
Dec. 19, 2022
Director908,265$11.01Buy$9,999,997.65
Quotient LtdTitleAmountPriceTypeTotal Value
Oct. 31, 2022
Major Shareholder8,255,607$0.08Sell$660,448.56
Sept. 15, 2020
Major Shareholder2,911,764$4.25Buy$12,374,997.00
Nov. 7, 2019
Major Shareholder2,500,000$7.00Buy$17,500,000.00
Albireo Pharma IncTitleAmountPriceTypeTotal Value
Oct. 13, 2022
Major Shareholder179,132$22.01Sell$3,942,695.32
Oct. 11, 2022
Major Shareholder144,065$23.54Sell$3,391,290.10
Feb. 3, 2020
Major Shareholder255,809$21.00Buy$5,371,989.00
LianBio ADRTitleAmountPriceTypeTotal Value
Aug. 18, 2022
Director998,240$2.40Buy$2,395,776.00
Cerevel Therapeutics Holdings IncTitleAmountPriceTypeTotal Value
Aug. 16, 2022
Director1,425,000$35.00Buy$49,875,000.00
Aug. 25, 2021
Director61,387$28.57Buy$1,753,826.59
Aug. 23, 2021
Director44,437$25.78Buy$1,145,585.86
July 7, 2021
Director200,000$25.00Buy$5,000,000.00
Aldeyra TheTitleAmountPriceTypeTotal Value
Aug. 10, 2022
Major Shareholder15,000$7.85Buy$117,750.00
Aug. 8, 2022
Major Shareholder97,000$7.24Buy$702,280.00
Aug. 3, 2022
Major Shareholder100,000$5.84Buy$584,000.00
Aug. 1, 2022
Major Shareholder144,185$5.05Buy$728,134.25
July 28, 2022
Major Shareholder119,392$5.00Buy$596,960.00
May 3, 2021
Major Shareholder1,200,000$12.50Buy$15,000,000.00
Jan. 19, 2021
Major Shareholder1,368,421$9.50Buy$12,999,999.50
Jan. 7, 2021
Major Shareholder500,000$8.13Buy$4,065,000.00
July 9, 2020
Major Shareholder3,200,000$4.25Buy$13,600,000.00
Feb. 14, 2017
Major Shareholder893,025$4.50Buy$4,018,612.50
May 26, 2016
Major Shareholder700,000$5.00Buy$3,500,000.00
Oct. 26, 2015
Major Shareholder50,000$6.46Buy$323,000.00
Oct. 22, 2015
Major Shareholder18,020$6.47Buy$116,589.40
Oct. 20, 2015
Major Shareholder37,145$6.39Buy$237,356.55
Verrica Pharmaceuticals IncTitleAmountPriceTypeTotal Value
July 5, 2022
Major Shareholder1,428,571$2.10Buy$2,999,999.10
Athira Pharma IncTitleAmountPriceTypeTotal Value
June 29, 2022
Director270,000$2.99Buy$807,300.00
Jan. 25, 2021
Director311,111$22.50Buy$6,999,997.50
Crinetics Pharmaceuticals IncTitleAmountPriceTypeTotal Value
April 18, 2022
Major Shareholder157,515$22.22Buy$3,499,983.30
Oct. 25, 2021
Major Shareholder1,200,000$19.80Buy$23,760,000.00
April 8, 2021
Major Shareholder304,136$16.44Buy$4,999,995.84
Nautilus Biotechnology IncTitleAmountPriceTypeTotal Value
Dec. 8, 2021
Director200,000$5.36Buy$1,072,000.00
VBI Vaccines IncTitleAmountPriceTypeTotal Value
Dec. 1, 2021
Major Shareholder2,707,463$3.31Sell$8,961,702.53
June 29, 2021
Major Shareholder646,257$3.80Sell$2,455,776.60
June 9, 2021
Major Shareholder1,422,567$4.00Sell$5,690,268.00
Sept. 23, 2019
Major Shareholder20,000,000$0.50Buy$10,000,000.00
Dec. 13, 2018
Major Shareholder14,285,714$1.40Buy$19,999,999.60
Dec. 6, 2016
Major Shareholder3,383,955$3.05Buy$10,321,062.75
Aug. 14, 2015
Major Shareholder650,000$2.08Buy$1,352,000.00
Agile ThrpeTitleAmountPriceTypeTotal Value
Oct. 13, 2021
Major Shareholder5,734,560$0.85Buy$4,874,376.00
March 13, 2020
Major Shareholder1,000,000$1.75Buy$1,750,000.00
Nov. 14, 2019
Major Shareholder435,015$1.69Buy$735,175.35
Oct. 28, 2019
Major Shareholder3,815,349$0.51Sell$1,945,827.99
Aug. 6, 2019
Major Shareholder2,300,000$0.95Buy$2,185,000.00
Rain Therapeutics IncTitleAmountPriceTypeTotal Value
Oct. 11, 2021
Major Shareholder21,826$12.51Sell$273,043.26
Oct. 7, 2021
Major Shareholder13,368$14.81Sell$197,980.08
April 27, 2021
Major Shareholder550,000$17.00Buy$9,350,000.00
ADMA Biologics IncTitleAmountPriceTypeTotal Value
Sept. 29, 2021
Major Shareholder82,505$1.16Sell$95,705.80
Sept. 27, 2021
Major Shareholder250,000$1.23Sell$307,500.00
Sept. 23, 2021
Major Shareholder780,000$1.27Sell$990,600.00
Aug. 19, 2021
Major Shareholder350,352$1.24Sell$434,436.48
Aug. 17, 2021
Major Shareholder879,092$1.35Sell$1,186,774.20
March 19, 2020
Major Shareholder500,000$2.10Buy$1,050,000.00
Feb. 11, 2020
Major Shareholder4,563,700$3.50Buy$15,972,950.00
Vyne Therapeutics IncTitleAmountPriceTypeTotal Value
Aug. 16, 2021
Major Shareholder250,000$1.74Sell$435,000.00
Aug. 12, 2021
Major Shareholder338,897$2.23Sell$755,740.31
May 6, 2021
Major Shareholder1,000,000$3.67Sell$3,670,000.00
Jan. 28, 2021
Major Shareholder4,219,409$2.37Buy$9,999,999.33
June 9, 2020
Major Shareholder2,702,702$1.85Buy$4,999,998.70
Solid Biosciences LLCTitleAmountPriceTypeTotal Value
March 23, 2021
Director2,608,695$5.75Buy$14,999,996.25
Prometheus Biosciences IncTitleAmountPriceTypeTotal Value
March 16, 2021
Major Shareholder850,000$19.00Buy$16,150,000.00
Landos Biopharma IncTitleAmountPriceTypeTotal Value
Feb. 8, 2021
Director1,250,000$16.00Buy$20,000,000.00
Scynexis IncTitleAmountPriceTypeTotal Value
Jan. 22, 2021
Major Shareholder319,000$8.24Sell$2,628,560.00
Jan. 20, 2021
Major Shareholder185,000$7.43Sell$1,374,550.00
Motus GI Holdings IncTitleAmountPriceTypeTotal Value
Jan. 22, 2021
Major Shareholder550,000$1.48Sell$814,000.00
Jan. 20, 2021
Major Shareholder325,648$1.80Sell$586,166.40
Athenex IncTitleAmountPriceTypeTotal Value
Sept. 14, 2020
Major Shareholder1,800,000$11.00Buy$19,800,000.00
Sept. 10, 2020
Major Shareholder200,000$11.24Buy$2,248,000.00
Oct. 16, 2019
Major Shareholder67,222$10.29Buy$691,714.38
Sept. 16, 2019
Major Shareholder30,000$13.58Buy$407,400.00
Sept. 12, 2019
Major Shareholder13,584$14.05Buy$190,855.20
Aug. 15, 2019
Major Shareholder30,000$15.00Buy$450,000.00
June 24, 2019
Major Shareholder20,786$17.90Buy$372,069.40
June 21, 2019
Major Shareholder23,073$17.85Buy$411,853.05
May 6, 2019
Major Shareholder100,000$12.71Buy$1,271,000.00
Leap Therapeutics IncTitleAmountPriceTypeTotal Value
June 22, 2020
Major Shareholder1,750,000$2.00Buy$3,500,000.00
Amicus Therapeutics IncTitleAmountPriceTypeTotal Value
Sept. 24, 2018
Major Shareholder20,000$12.45Buy$249,000.00
March 5, 2018
Major Shareholder335,827$13.56Buy$4,553,814.12
Dec. 30, 2016
Major Shareholder94,750$4.96Buy$469,960.00
Dec. 29, 2016
Major Shareholder142,125$4.87Buy$692,148.75
Dec. 23, 2016
Major Shareholder85,275$4.81Buy$410,172.75
Dec. 22, 2016
Major Shareholder189,500$4.51Buy$854,645.00
Aug. 25, 2016
Insider1,100,000$6.81Sell$7,491,000.00
Oct. 7, 2015
Major Shareholder50,000$6.27Buy$313,500.00
Oct. 6, 2015
Major Shareholder750,000$6.71Buy$5,032,500.00
Nov. 19, 2014
Major Shareholder2,100,000$6.50Buy$13,650,000.00
June 30, 2014
Major Shareholder4,000,000$3.50Buy$14,000,000.00
Global Blood Therapeutics IncTitleAmountPriceTypeTotal Value
Dec. 19, 2017
Major Shareholder175,000$38.00Buy$6,650,000.00
AcelRx Pharmaceuticals IncTitleAmountPriceTypeTotal Value
Sept. 29, 2016
Major Shareholder216,500$3.92Sell$848,680.00
Sept. 15, 2016
Major Shareholder392,850$3.70Sell$1,453,545.00
Nov. 18, 2015
Major Shareholder176,200$5.35Sell$942,670.00
Nov. 6, 2015
Major Shareholder92,100$4.59Sell$422,739.00
Sept. 9, 2015
Major Shareholder310,000$4.18Sell$1,295,800.00
Nov. 7, 2013
major shareholder200,000$6.51Buy$1,302,000.00
Nov. 4, 2013
major shareholder155,000$6.87Buy$1,064,850.00
Nov. 1, 2013
Major Shareholder360,660$6.91Buy$2,492,160.60
July 23, 2013
Major Shareholder850,000$11.65Buy$9,902,500.00